| 000 | 01850 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516104706.0 | ||
| 264 | 0 | _c20140602 | |
| 008 | 201406s 0 0 eng d | ||
| 022 | _a1297-9716 | ||
| 024 | 7 |
_a10.1186/1297-9716-43-59 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDomínguez-Bernal, Gustavo | |
| 245 | 0 | 0 |
_aMitigating an undesirable immune response of inherent susceptibility to cutaneous leishmaniosis in a mouse model: the role of the pathoantigenic HISA70 DNA vaccine. _h[electronic resource] |
| 260 |
_bVeterinary research _cAug 2012 |
||
| 300 |
_a59 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCloning, Molecular |
| 650 | 0 | 4 | _aCross Protection |
| 650 | 0 | 4 |
_aCytokines _xgenetics |
| 650 | 0 | 4 |
_aDisease Susceptibility _ximmunology |
| 650 | 0 | 4 |
_aEnzyme-Linked Immunosorbent Assay _xveterinary |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aImmunity, Humoral |
| 650 | 0 | 4 |
_aLeishmania _xphysiology |
| 650 | 0 | 4 |
_aLeishmania major _ximmunology |
| 650 | 0 | 4 |
_aLeishmaniasis Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aLeishmaniasis, Cutaneous _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aParasite Load _xveterinary |
| 650 | 0 | 4 |
_aPolyproteins _xgenetics |
| 650 | 0 | 4 |
_aProtozoan Proteins _xgenetics |
| 650 | 0 | 4 |
_aVaccination _xveterinary |
| 650 | 0 | 4 |
_aVaccines, DNA _xadministration & dosage |
| 700 | 1 | _aHorcajo, Pilar | |
| 700 | 1 | _aOrden, José A | |
| 700 | 1 | _aDe La Fuente, Ricardo | |
| 700 | 1 | _aHerrero-Gil, Aldara | |
| 700 | 1 | _aOrdóñez-Gutiérrez, Lara | |
| 700 | 1 | _aCarrión, Javier | |
| 773 | 0 |
_tVeterinary research _gvol. 43 _gp. 59 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1297-9716-43-59 _zAvailable from publisher's website |
| 999 |
_c22011110 _d22011110 |
||